A Phase 1b Study to Investigate the Safety, Efficacy and Pharmacodynamics of Cerdulatinib for the Treatment of Atopic Dermatitis
Latest Information Update: 21 Dec 2018
At a glance
- Drugs Cerdulatinib (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Biomarker; Pharmacodynamics; Pharmacogenomic; Proof of concept; Therapeutic Use
Most Recent Events
- 21 Dec 2018 New trial record
- 10 Dec 2018 Results published in the Experimental Dermatology Journal: 3rd Inflammatory Skin Disease Summit-The Translational Revolution.
- 06 Dec 2018 According to a Dermavant Sciences media release, data from this trial will be presented at the 3rd Annual Inflammatory Skin Disease Summit (ISDS) taking place (12-15th Dec, 2018, Vienna, Austria).